Avrobio is based out of Cambridge. Avrobio, Inc. operates as a bio-technology company. The Company develops step-change cell and gene therapies for the treatment of cancer and rare disease. Avrobio serves clients in the United States and Canada. The firm last filed a Form D notice of exempt offering of securities on 2018-02-02. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
AVROBIO, Inc.100 TECHNOLOGY SQUARE
CAMBRIDGE MA 02139
Business Phone: 617.914.8420
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)